BHST Bioharvest Sciences Inc.
Fundamentals / CIK 0001723464 / USDBioharvest Sciences Inc. reported $34.51M in revenue and a net loss of $11.13M for the fiscal year ended December 31, 2025 (up 37.0% year over year), with a 59.3% gross margin and a -16.2% operating margin.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open BHST in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2025$34.51M +37.0% YoY
-
Operating Income FY 2025-$5.58M -16.2% margin
-
Net Income FY 2025-$11.13M -32.3% net margin
-
Diluted EPS FY 2025-- Split-adjusted
-
Free Cash Flow FY 2025-$9.58M -27.8% FCF margin
-
Cash & ST Investments Dec 31, 2025$23.02M Total debt: $10.28M
Annual revenue and net income
3 fiscal years (2023 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|
| Revenue | $34.51M | $25.19M | $12.67M |
| Cost of Revenue | $14.03M | $11.25M | $7.04M |
| Gross Profit | $20.48M | $13.94M | $5.63M |
| Research & Development | $5.31M | $4.80M | $3.37M |
| Selling, General & Admin | $20.74M | $16.13M | $12.23M |
| Total Operating Expenses | $26.05M | $20.93M | $15.60M |
| Operating Income | -$5.58M | -$6.99M | -$9.97M |
| EBITDA | -$3.95M | -$5.74M | -$9.13M |
| Income Before Tax | -$11.06M | -$12.90M | -$12.56M |
| Income Tax Expense | -$76K | -$8.0K | $0 |
| Net Income | -$11.13M | -$12.91M | -$12.56M |
| Basic EPS | -$0.60 | -$0.80 | -$0.93 |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|
| Cash & Cash Equivalents | $23.02M | $2.39M | $5.36M |
| Cash & Short-Term Investments | $23.02M | $2.39M | $5.36M |
| Accounts Receivable, Net | $1.98M | $1.12M | $808K |
| Inventory | $4.56M | $3.65M | $2.47M |
| Total Current Assets | $30.50M | $7.86M | $9.05M |
| Property, Plant & Equipment, Net | $8.33M | $7.75M | $3.93M |
| Total Non-Current Assets | $17.16M | $17.14M | $5.95M |
| Total Assets | $47.66M | $25.00M | $15.00M |
| Accounts Payable | $2.63M | $3.52M | $1.78M |
| Short-Term Debt | $149K | $3.90M | $0 |
| Other Current Liabilities | $452K | $1.14M | $0 |
| Total Current Liabilities | $7.68M | $14.26M | $26.47M |
| Other Non-Current Liabilities | $1.98M | $272K | $1.96M |
| Total Non-Current Liabilities | $14.53M | $9.41M | $3.39M |
| Total Liabilities | $22.22M | $23.67M | $29.86M |
| Total Debt (incl. Leases) | $10.28M | $13.05M | $1.43M |
| Retained Earnings | -$107.6M | -$96.42M | -$83.50M |
| Total Stockholders' Equity | $25.45M | $1.33M | -$14.85M |
| Total Equity | $25.45M | $1.33M | -$14.85M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Cash & Cash Equivalents | $23.02M | $2.39M | $5.36M |
| Cash & Short-Term Investments | $23.02M | $2.39M | $5.36M |
| Accounts Receivable, Net | $1.98M | $1.12M | $808K |
| Inventory | $4.56M | $3.65M | $2.47M |
| Total Current Assets | $30.50M | $7.86M | $9.05M |
| Property, Plant & Equipment, Net | $8.33M | $7.75M | $3.93M |
| Total Non-Current Assets | $17.16M | $17.14M | $5.95M |
| Total Assets | $47.66M | $25.00M | $15.00M |
| Accounts Payable | $2.63M | $3.52M | $1.78M |
| Short-Term Debt | $149K | $3.90M | $0 |
| Other Current Liabilities | $452K | $1.14M | $0 |
| Total Current Liabilities | $7.68M | $14.26M | $26.47M |
| Other Non-Current Liabilities | $1.98M | $272K | $1.96M |
| Total Non-Current Liabilities | $14.53M | $9.41M | $3.39M |
| Total Liabilities | $22.22M | $23.67M | $29.86M |
| Total Debt (incl. Leases) | $10.28M | $13.05M | $1.43M |
| Retained Earnings | -$107.6M | -$96.42M | -$83.50M |
| Total Stockholders' Equity | $25.45M | $1.33M | -$14.85M |
| Total Equity | $25.45M | $1.33M | -$14.85M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|
| Net Income | -$11.13M | -$12.91M | -$12.56M |
| Depreciation & Amortization | $1.62M | $1.25M | $840K |
| Stock-Based Compensation | -- | $601K | $563K |
| Change in Receivables | -$865K | -$308K | -$262K |
| Change in Inventory | -$904K | -$1.19M | -$1.09M |
| Operating Cash Flow | -$7.23M | -$6.68M | -$8.52M |
| Capital Expenditure | -$2.35M | -$2.83M | -$1.47M |
| Free Cash Flow | -$9.58M | -$9.52M | -$10.00M |
| Investing Cash Flow | -$2.37M | -$3.03M | -$1.47M |
| Common Stock Issued | $18.26M | $0 | $0 |
| Financing Cash Flow | $30.19M | $6.78M | $13.56M |
| Net Change in Cash | $20.60M | -$2.93M | $3.56M |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|
| Gross Margin | 59.3% | 55.4% | 44.5% |
| Operating Margin | -16.2% | -27.7% | -78.6% |
| Net Profit Margin | -32.3% | -51.3% | -99.1% |
| Return on Equity (ROE) | -43.8% | -970.9% | -- |
| Return on Assets (ROA) | -23.4% | -51.6% | -83.7% |
| Current Ratio | 3.97x | 0.55x | 0.34x |
| Quick Ratio | 3.38x | 0.29x | 0.25x |
| Debt to Equity | 0.40x | 9.81x | -- |
| Revenue Growth (YoY) | +37.0% | +98.8% | -- |
| Gross Profit Growth (YoY) | +46.9% | +147.5% | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.